CRISPR Discoverer Joins Max Planck Institute
This article was originally published in Scrip
Emmanuelle Charpentier, who was named one of the "most influential scientists" by Time magazine when she co-discovered of CRISPR-Cas9, is joining the Max Planck Institute for Infection Biology, Berlin, in Oct. 2015, as a director. The French molecular biologist will be tasked with setting up a new department at the institute, which will explore the regulatory processes in bacterial infectious diseases.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.